Clinical Trial Update: A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

Early-phase study update on intratumoral microdose administration of PBA-0405 in solid tumors; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Soft Tissue Sarcoma
• Triple-negative Breast Cancer

Drugs mentioned

• PBA-0405 (PBA-0405)

Snippet

Sponsor: Pure Biologics S.A. | Conditions: Head and Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult | EARLY_Phase 1 | Status: COMPLETED